Circulating extracellular vesicles are monitoring biomarkers of anti-PD1 response and enhancer of tumor progression and immunosuppression in metastatic melanoma by Simona Serratì, Roberta Di Fonte, Letizia Porcelli, Simona De Summa, Ivana De Risi, Livia Fucci, Eustachio Ruggieri, Tommaso Maria Marvulli, Sabino Strippoli, Rossella Fasano, Tania Rafaschieri, Gabriella Guida, Michele Guida, Amalia Azzariti

Subjects: Get full text

Programmed cell death 1 checkpoint inhibitors in the treatment of patients with advanced melanoma by Jacek Mackiewicz, Andrzej Mackiewicz

Subjects: Get full text

Optimum fractionation of radiation to combine PD‐1 blockade by Feifei Teng, Tianwen Yin, Xiao Ju, Peiliang Wang, Yungang Wang, Jinming Yu

Subjects: “…anti‐PD‐1…”
Get full text

Myeloid-Derived Suppressor Cells (MDSC) in Melanoma Patients Treated with Anti-PD-1 Immunotherapy by Katarzyna Tomela, Bernadeta Pietrzak, Łukasz Galus, Jacek Mackiewicz, Marcin Schmidt, Andrzej Adam Mackiewicz, Mariusz Kaczmarek

Subjects: Get full text

Real world evidence of Lenvatinib + anti PD-1 as an advanced line for metastatic melanoma by Ronen Stoff, Nethanel Asher, Shachar Laks, Yael Steinberg, Jacob Schachter, Ronnie Shapira-Frommer, Shirly Grynberg, Guy Ben-Betzalel

Subjects: Get full text

A T-cell-dependent antibody response study using a murine surrogate anti-PD-1 monoclonal antibody as an alternative to a non-human primate model by Lisa M. Plitnick, Beth Hutchins, Sheri Dubey, Nianyu Li, Rupesh P. Amin, Stephanie Born, Ruban Mangadu, Joseph H. Phillips, Venkataraman Sriram, Danuta J. Herzyk

Subjects: “…anti-pd-1…”
Get full text

Efficacy and Safety of Sintilimab in Combination with Concurrent Chemoradiotherapy for Locally Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (SHARED): Study Pr... by Wei J, Lu X, Liu Q, Fu Y, Liu S, Li L, Liu F, Fan X, Yang J, Yang Y, Zhao Y, Guan W, Liu B

Subjects: “…anti-pd-1…”
Get full text

Multimodal Integrative Genomics and Pathology Analyses in Neoadjuvant Nivolumab Treatment for Intermediate and Locally Advanced Hepatocellular Carcinoma by Tan-To Cheung, Daniel Wai-Hung Ho, Shirley Xueying Lyu, Qingyang Zhang, Yu-Man Tsui, Tiffany Ching-Yun Yu, Karen Man-Fong Sze, Joyce Man-Fong Lee, Vince Wing-hang Lau, Edward Yin-Lun Chu, Simon Hing-Yin Tsang, Wong-Hoi She, Roland Ching-Yu Leung, Thomas Chung-Cheung Yau, Irene Oi-Lin Ng

Subjects: “…anti-pd-1…”
Get full text

Blood Predictive Biomarkers for Nivolumab in Advanced Melanoma by Edouard Chasseuil, Mélanie Saint-Jean, Hannah Chasseuil, Lucie Peuvrel, Gaëlle Quéreux, Jean-Michel Nguyen, Aurélie Gaultier, Emilie Varey, Amir Khammari, Brigitte Dréno

Subjects: Get full text

Anti PD-1 protitelesa by Janja Ocvirk

Subjects: Get full text

Successful treatment with anti-programmed-death-1 antibody in a relapsed natural killer/T-cell lymphoma patient with multi-line resistance: a case report by Jianping Lai, Peng Xu, Xiaoliu Jiang, Shan Zhou, Anwen Liu

Subjects: Get full text

Subclone from CT26 resistant to anti-PD-1 therapy associated with increased expression of genes related to glucocorticoids by Yangyang Zhang, Chaoji Zhang, Guangyu Chen, Hongqin You, Sen Wang, Xiaoming Wang, Peng Zhao, Benling Xu, Quanli Gao, Long Yuan

Subjects: Get full text

Gut microbiome affects the response to anti-PD-1 immunotherapy in patients with hepatocellular carcinoma by Yi Zheng, Tingting Wang, Xiaoxuan Tu, Yun Huang, Hangyu Zhang, Di Tan, Weiqin Jiang, Shunfeng Cai, Peng Zhao, Ruixue Song, Peilu Li, Nan Qin, Weijia Fang

Subjects: Get full text

TIM3 expression on tumor cells predicts response to anti-PD-1 therapy for renal cancer by Renpei Kato, Noriaki Jinnouchi, Takashi Tuyukubo, Daiki Ikarashi, Tomohiko Matsuura, Shigekatsu Maekawa, Yoichiro Kato, Mitsugu Kanehira, Ryo Takata, Kazuyuki Ishida, Wataru Obara

Subjects: Get full text

A Mathematical Model for the Treatment of Melanoma with the BRAF/MEK Inhibitor and Anti-PD-1 by OPhir Nave, Moriah Sigron

Subjects: “…Anti-PD-1…”
Get full text

Physical activity improves outcomes of combined lenvatinib plus anti-PD-1 therapy in unresectable hepatocellular carcinoma: a retrospective study and mouse model by Xue-Feng Liu, Xiao-Dong Zhu, Long-Hai Feng, Xiao-Long Li, Bin Xu, Kang-Shuai Li, Nan Xiao, Ming Lei, Hui-Chuan Sun, Zhao-You Tang

Subjects: Get full text

Conversion of unresponsiveness to immune checkpoint inhibition by fecal microbiota transplantation in patients with metastatic melanoma: study protocol for a randomized phase Ib/II... by J. S. W. Borgers, F. H. Burgers, E. M. Terveer, M. E. van Leerdam, C. M. Korse, R. Kessels, C. C. Flohil, C. U. Blank, T. N. Schumacher, M. van Dijk, J. G. E. Henderickx, J. J. Keller, H. W. Verspaget, E. J. Kuijper, J. B. A. G. Haanen

Subjects: Get full text

Anti–PD-1 in Combination With Trametinib Suppresses Tumor Growth and Improves Survival of Intrahepatic Cholangiocarcinoma in MiceSummary by Simon Wabitsch, Mayank Tandon, Benjamin Ruf, Qianfei Zhang, Justin D. McCallen, John C. McVey, Chi Ma, Benjamin L. Green, Laurence P. Diggs, Bernd Heinrich, Tim F. Greten

Subjects: Get full text

Immunosuppressive Effects of Myeloid-Derived Suppressor Cells in Cancer and Immunotherapy by Mithunah Krishnamoorthy, Lara Gerhardt, Saman Maleki Vareki

Subjects: Get full text

Anti-PD-1 antibody decreases tumour-infiltrating regulatory T cells by Kazushige Yoshida, Masanori Okamoto, Jun Sasaki, Chika Kuroda, Haruka Ishida, Katsuya Ueda, Hirokazu Ideta, Takayuki Kamanaka, Atsushi Sobajima, Takashi Takizawa, Manabu Tanaka, Kaoru Aoki, Takeshi Uemura, Hiroyuki Kato, Hisao Haniu, Naoto Saito

Subjects: Get full text